Mannkind Partnership To Sell Afrezza







MannKind - Afrezza Script Sales Data Collection

Jun. 13, 2016 9:58 AM • MNKD

Summary

  • Afrezza script sales were a bit above 280 this past week.
  • New scripts are trending down.
  • Refills are trending down.
 






























This is inaccurate. I was contacted very recently for an opening that is not any of those cities.
Not surprising. This entire project has been a total clusterf*ck: MannKind's C-level exec Constangna(aka A hole) mis-"tweeting" about all jobs filled like he were Kim Kardashian, Touchpoint's grossly disorganized "recruiting" ( which degrades the currency of the term "recruiting"). They don't even bother to email the "passed over" candidates (after HireVue, Skype and multiple phone interviews) to let them know. Touchpoint & MannKind: the Laurel & Hardy of 21st Century pharma. If MNKD stock weren't already in the toilet, I'd short it.